DIRTT ENVIRONMENTAL SOLUTIONS LTD (DRTTF) stock intrinsic value fair value estimate & owner earnings analysis

DIRTT Environmental Solutions makes prefabricated interior construction systems: modular walls, doors, millwork and related components that are designed in its own ICE software, manufactured in its plants, and sold and installed through a network of independent Construction Partners. Almost all revenue comes from North America: $149.4 million from the United States and $19.4 million from Canada in 2025, for a total of $168.9 million. Customers are mainly commercial offices, with growing healthcare, education and government work. Healthcare sales rose to $40.3 million in 2025 from $21.2 million in 2024, while commercial sales fell to $98.0 million from $121.5 million. The record: For most of the last nine years, this business has used more cash than it produced. We measure the cash an owner could take out each year: operating cash flow, with working-capital timing swings removed, less stock-based pay (which we count as a real cost), less the capital spending needed to keep the business running. We include capitalized software spending in that capital spending. On that basis the company lost about $52 million in 2021 and $44 million in 2022. After closing plants, including the Rock Hill, South Carolina factory in 2023, cutting capital spending from roughly $14–19 million a year to about $3–4 million, and running a series of reorganizations, the results got closer to break-even. The company lost $4.9 million in 2023, made $7.3 million in 2024 and lost $6.8 million in 2025. In 2025, delayed orders early in the year and tariff costs cut gross profit by $8.9 million, and reorganization costs were $4.9 million. Accounting judgements: We left out two large non-cash gains that flattered reported profit: a $10.4 million gain on buying back convertible debt below face value in 2024, and a $7.1 million gain on the 2023 sale of software and patents. We added back impairment write-downs because they are not cash. We did not treat reorganization costs as one-time. The company has booked them every year from 2023 through the first half of 2026, including $3.4 million so far in 2026. We measure the business from 2023 onward, after the restructuring, because the earlier years describe a larger company with more plants. The middle result of 2023–2025 is a loss of about 3.5 cents per share, and that is our starting level. What has changed: The first half of 2026 was clearly better. Revenue rose 3% to $82.7 million. Selling and administrative costs fell about $2.5 million after the 2025 job cuts. Before reorganization costs, the company made an operating profit of about $1.5 million, against a loss of about $4.3 million a year earlier. Two more things should keep helping: the lease on the closed Rock Hill plant was ended early on December 30, 2025, and the January convertible debentures (C$16.6 million) were paid off on January 31, 2026, which cuts interest. Base case: Owner earnings turn positive at about $2 million over the next year, as the first-half 2026 improvement is partly offset by more reorganization spending. After that they settle at about $4 million a year, below the $7.3 million of 2024 and consistent with the lower cost base. Revenue stays flat, as it has at $169–182 million since 2022. We have no evidence that this business can hold its earnings over the long run: across 2017–2025 it lost well over $100 million in total. So the base case fades earnings to zero over years 11 to 15. That gives about 16 cents per share ($0.16). Bear case: The 2025 pattern comes back: orders slip, tariffs squeeze margins and reorganizations continue. Losses run about $6.8 million in the first year and $4 million in each of the next two, before cost cuts or outside capital bring the business to break-even. Debt makes this worse. C$14.8 million of December debentures are due on December 31, 2026, and the main bank line matures on November 30, 2026. In December 2025 the company bought back its own shares while it was below a debt-coverage requirement and needed a waiver from its bank. On this path the business uses about $13 million more cash than it produces, so the shares are worth about minus 7 cents (−$0.07). In other words, the company would owe more than it is worth by roughly $13 million. Shareholders would have to cover the gap, either by putting in new money or by accepting dilution. Bull case: The first-half 2026 cost savings hold, the reorganization program ends in 2026 as the company plans, and healthcare growth replaces the lost commercial volume. Owner earnings reach about $9 million a year, a little above the 2024 level, and then fade over years 11 to 15. That gives about 36 cents per share ($0.36). What would prove this wrong: On the upside, if the company can show several years of positive owner earnings with reorganization costs actually ending, the base case would be too low. On the downside, if it has to refinance or settle the December 2026 debentures on costly terms, or 2025-style order delays return, the value moves toward the bear case. Capital spending of $3.7 million in 2025 was well below depreciation and amortization of $6.2 million. If the plants need catching-up investment, that cost is not in these numbers. A note on the figures: share counts before 2023 were adjusted for the 2023 rights offering. The 2024 count includes convertible debentures as if converted, as the company reported it.